Answers are grounded in this paper and cite their sources.
In the era of targeted therapy and sophisticated risk stratification, every attempt must be made to perform a complete workup on MS cases (or concurrent AML) since the diagnosis of MS, in itself, is no longer adequate for patient management. Cases of blastic plasmacytoid dendritic cell neoplasm were also included and discussed in this session.
No takes yet. Share an insight, caveat, or question.
Wilson et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: